Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT03059147 · TERMINATED
Trial details
- NCT number
- NCT03059147
- Sponsor
- SignalRX Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2019-04-22
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.